Strategies for diagnosis of HTLV-I and -II. (Q34765912)

4 August 2017

title

Strategies for diagnosis of HTLV-I and -II. (English)

1 reference

Human T-lymphotropic virus 1

4 August 2017

main subject

0 references

3

Sören Andersson

1 reference

4 August 2017

Rigmor Thorstensson

1

1 reference

4 August 2017

Jon Albert

series ordinal

2

1 reference

4 August 2017

language of work or name

1 reference

1 June 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

42

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

780-791

1 reference

Spastic ataxia associated with human T-cell lymphotropic virus type II infection

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

High Prevalence of Human T Cell Lymphotropic Virus Type II Infection in Patients Affected by Human Immunodeficiency Virus Type 1-Associated Predominantly Sensory Polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Comparative performances of an HTLV-I/II EIA and other serologic and PCR assays on samples from persons at risk for HTLV-II infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Comparative evaluation of 14 immunoassays for detection of antibodies to the human T-lymphotropic virus types I and II using panels of sera from Sweden and West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Simultaneous confirmation and differentiation of human T-lymphotropic virus types I and II infection by modified western blot containing recombinant envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

High rate of indeterminate reactivity to HTLV in western blot analysis of Spanish blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Low HTLV-I/II seroprevalence in pregnant women in Congo and a geographic cluster of an HTLV-like indeterminate western blot pattern.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Evaluation of a new HTLV-I/II polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Significance of indeterminate reactivity to human T-cell lymphotropic virus in western blot analysis of individuals at risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

New strip immunoblot for the confirmation of HTLV-I/II infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T-lymphotropic virus infection in French blood donors. Retrovirus Study Group of the French Society of Blood Transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Comparative performances of enzyme-linked immunosorbent, western blot, and polymerase chain reaction assays for human T-lymphotropic virus type II infection that is endemic among Indians of the Gran Chaco region of South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

High prevalence of false-negative anti-HTLV type I/II enzyme-linked immunosorbent assay results in HIV type 1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Reexamination of human T cell lymphotropic virus (HTLV-I/II) prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Molecular epidemiology and MT-2 cell tropism of Russian HIV type 1 variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Comparison of four HTLV-I and HTLV-I + II ELISAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Dependency of antibody titer on provirus load in human T lymphotropic virus type I carriers: an interpretation for the minor population of seronegative carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

Evaluation of the WHO human immunodeficiency virus (HIV) antibody testing strategy for the diagnosis of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2002.00114.X

10.1046/J.1537-2995.2002.00114.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference